Population
Patients susceptible to malignant hyperthermia (MHS)
Design
Review
Authors
Loading...
Emphasizes MH preparedness in anesthesia despite low mortality; leaves open mutation-specific therapies pending prospective validation.
This review summarizes the pathophysiology, diagnosis, and management of malignant hyperthermia, highlighting the role of abnormal ryanodine receptors.
Erica McCarthy (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: